Deficit of CD38/cyclic ADP-ribose is differentially compensated in hearts by gender

Biochemical and Biophysical Research Communications

Volumn 312, Issue 2, 2003, Pages 434-440

  Takahashi, Jun ^a   Kagaya, Yutaka ^a   Kato, Ichiro ^b   Ohta, Jun ^a   Isoyama, Shogen ^c   Miura, Masahito ^a   Sugai, Yoshinao ^a   Hirose, Masanori ^a   Wakayama, Yuji ^a   Ninomiya, Mototsugu ^a   Watanabe, Jun ^a   Takasawa, Shin ^a   Okamoto, Hiroshi ^a   Shirato, Kunio ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c TOHOKU BUNKA GAKUEN UNIVERSITY   (Japan)

Author keywords

Calcium cycling; CD38; Cyclic ADP ribose; Gender difference; Hypertrophy

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; CD38 ANTIGEN; PHOSPHOLAMBAN; RYANODINE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONTROLLED STUDY; FEMALE; HEART; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HEART PAPILLARY MUSCLE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; SEX DIFFERENCE; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 10744226039     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.10.143     Document Type: Article

References (26)

1. Eisner D.A., Choi H.S., Diaz M.E., O'Nell S.C., Trafford A.W. Integrative analysis of calcium cycling in cardiac muscle. Circ. Res. 87:2000;1087-1094.
2. 2+ release in sea urchin egg homogenates: modulation by cyclic ADP-ribose. Science. 253:1991;1143-1146.
3. Takasawa S., Nata K., Yonekura H., Okamoto H. Cyclic ADP-ribose in insulin secretion from pancreatic β cells. Science. 259:1993;370-373.
4. 2+ channel. Nature. 364:1993;76-79.
5. 2+ release in intact cardiac myocyte. Circ. Res. 79:1996;147-151.
6. Rakovic S., Galione A., Ashamu G.A., Potter B.V., Terrar D.A. A specific cyclic ADP-ribose antagonist inhibits cardiac excitation-contraction coupling. Curr. Biol. 6:1996;989-996.
7. Iino S., Cui Y., Galione A., Terrar D.A. Actions of cADP-ribose and its antagonists on contraction in guinea pig isolated ventricular myocytes. Influence of temperature. Circ. Res. 81:1997;879-884.
8. Mészáros V., Socci R., Mészáros L.G. The kinetics of cyclic ADP-ribose formation in heart muscle. Biochem. Biophys. Res. Commun. 210:1995;452-456.
9. Takasawa S., Tohgo A., Noguchi N., Koguma T., Nata K., Sugimoto T., Yonekura H., Okamoto H. Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J. Biol. Chem. 268:1993;26052-26054.
10. i, and insulin secretion. J. Biol. Chem. 274:1999;1869-1872.
11. 2+ signaling using CD38 knockout mice. J. Biol. Chem. 276:2001;649-655.
12. Manning W.J., Wei J.Y., Katz S.E., Litwin S.E., Douglas P.S. In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. Am. J. Physiol. 266:1994;H1672-1675.
13. Kagaya Y., Kanno Y., Takeyama D., Ishide N., Maruyama Y., Takahashi T., Ido T., Takishima T. Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats. A quantitative autoradiographic study. Circulation. 81:1990;1353-1361.
14. 2+ mobilization in normal and diabetic β-cells. J. Biol. Chem. 273:1998;2497-2500.
15. 2+ waves during triggered propagated contractions in intact trabeculae. Determinants of the velocity of propagation. Circ. Res. 84:1999;1459-1468.
16. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
17. 2+-ATPase (SERCA2) gene products are regulated post-transcriptionally during rat cardiac development. Cardiovasc. Res. 43:1999;426-436.
18. 2+-release channel. Circ. Res. 75:1994;596-600.
19. 2+ affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. J. Biol. Chem. 275:2000;12129-12135.
20. Sato Y., Ferguson D.G., Sako H., Dorn II G.W., Kadambi V.J., Yatani A., Hoit B.D., Walsh R.A., Kranias E.G. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J. Biol. Chem. 273:1998;28470-28477.
21. Minamisawa S., Hoshijima M., Chu G., Ward C.A., Frank K., Gu Y., Martone M.E., Wang Y., Ross J. Jr., Kranias E.G., Giles W.R., Chien K.R. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell. 99:1999;313-322.
22. Hoshijima M., Ikeda Y., Iwanaga Y., Minamisawa S., Date M.O., Gu Y., Iwatate M., Li M., Wang L., Wilson J.M., Wang Y., Ross J. Jr., Chien K.R. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat. Med. 8:2002;864-871.
23. 2+-ATPase in a rat model of heart failure. Circulation. 104:2001;1424-1429.
24. Diaz M.E., Trafford A.W., O'Neill S.C., Eisner D.A. Can changes of ryanodine receptor expression affect cardiac contractility? Cardiovasc. Res. 45:2000;1068-1069.
25. van Eickels M., Grohe C., Cleutjens J.P., Janssen B.J., Wellens H.J., Doevendans P.A. 17β-Estradiol attenuates the development of pressure-overload hypertrophy. Circulation. 104:2001;1419-1423.
26. Xin H.B., Senbonmatsu T., Cheng D.S., Wang Y.X., Copello J.A., Ji G.J., Colllier M.L., Deng K.Y., Jeyakumar L.H., Magnuson M.A., Inagami T., Kotlikoff M.I., Fleischer S. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature. 416:2002;334-337.